Both ligands are expressed on antigen presenting cells (APCs) and many non-hematopoietic cell types, including tumor cells, and share a signaling network with the costimulatory receptor CD226 (DNAM-1) [5, 6]. This evidence concerns the gene CD226 and neoplasm.